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Transcription elongation is increasingly recognized
as an important mechanism of gene regulation.
Here, we show that microprocessor controls gene
expression in an RNAi-independent manner. Micro-
processor orchestrates the recruitment of termina-
tion factors Setx and Xrn2, and the 30–50 exoribonu-
clease, Rrp6, to initiate RNAPII pausing and
premature termination at the HIV-1 promoter through
cleavage of the stem-loop RNA, TAR. Rrp6 further
processes the cleavage product, which generates
a small RNA that is required to mediate potent tran-
scriptional repression and chromatin remodeling at
the HIV-1 promoter. Using chromatin immunoprecip-
itation coupled to high-throughput sequencing
(ChIP-seq), we identified cellular gene targets whose
transcription is modulated by microprocessor. Our
study reveals RNAPII pausing and premature
termination mediated by the co-operative activity of
ribonucleases, Drosha/Dgcr8, Xrn2, and Rrp6, as a
regulatory mechanism of RNAPII-dependent tran-
scription elongation.
INTRODUCTION
Many cellular genes, in particular highly inducible genes,
undergo transcriptional initiation but are regulated at the level
of transcriptional elongation (Guenther et al., 2007). Indeed,
genome-wide mapping studies have shown that transcription
initiation from cellular genes is extremely pervasive, confirming
promoter-proximal RNA polymerase II (RNAPII) pausing as an
important mechanism of transcriptional control (Affymetrix
ENCODE Transcriptome Project; Cold Spring Harbor LaboratoryCENCODE Transcriptome Project, 2009; Core and Lis, 2008; Core
et al., 2008; Seila et al., 2008). Nucleosome architecture profiles
have been correlated with the tendency for a promoter to
undergo pausing (Gilchrist et al., 2010). However, the mecha-
nisms that control RNAPII pausing are poorly understood. Tran-
scription factors that contribute to pausing have been clearly
identified. Furthermore, whereas a regulatory role for the small
promoter-associated RNA products of such abortive transcrip-
tion has been speculated (Affymetrix ENCODE Transcriptome
Project; Cold Spring Harbor Laboratory ENCODE Transcriptome
Project, 2009; Core and Lis, 2008; Core et al., 2008; Seila et al.,
2008), the mechanisms controlling their processing and function
remain to be discovered.
The HIV type 1 (HIV-1) promoter is a well-defined, convenient,
and thus widely used model, which has provided considerable
insight into transcriptional elongation control. In the absence of
the viral transactivator Tat, transcription from the long terminal
repeat (LTR) leads to RNAPII pausing and premature termination
after synthesis of a short stem-loop RNA, the transactivation
response element (TAR) (Bre`s et al., 2008). HIV-1 Tat, together
with the positive transcription elongation factor PTEF-b, binds
a bulge-loop within TAR, allowing CDK9 to phosphorylate
RNAPII CTD at serine 2 and NTEFs (Negative Transcription Elon-
gation factors), licensing RNAPII for productive elongation (Bre`s
et al., 2008). The molecular mechanisms involved in RNAPII
pausing and premature termination at the HIV-1 promoter are
unknown.
The microprocessor complex that consists of at least two
subunits, the RNase III Drosha and the dsRNA-binding protein
Dgcr8, is required for the regulation ofmaturemiRNA abundance
(Han et al., 2009; Kim et al., 2009). Microprocessor is essential
for the first processing step characterized by recognition of the
canonical stem-loop structure of the miRNA by Dgcr8. Drosha
cleaves both strands of the primary transcript (pri-miRNA) at
sites near the base of the stem loop that liberates the precursor
miRNA (pre-miRNA), which is further processed in the cytoplasmell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc. 1147
by Dicer (Newman and Hammond, 2010; Seitz and Zamore,
2006). The mature miRNA mediates posttranscriptional gene
silencing (PTGS) through translational inhibition and destabiliza-
tion of the target mRNA (Han et al., 2009). Interestingly, PTGS-
independent regulation of gene expression in mammalian cells
by the microprocessor has been suggested by Han et al.
(2009). However, the molecular mechanism for this function of
the microprocessor is unknown.
Transcriptional termination of several classes of RNA in yeast
occurs via a complex containing the RNA/DNA helicase, Sen1
(Steinmetz et al., 2006; Ursic et al., 1997). The Sen1 termination
complex associates with RNAPII near promoters and appears to
be most important for termination within 500 bp of transcription
start sites (TSSs) (Kim et al., 2010; Steinmetz et al., 2006). Sen1-
mediated termination is potentiated by a 50–30 exoribonuclease,
Rat1p/Xrn2, that, following cleavage, degrades the uncapped
nascent transcript to promote the release of RNAPII from its
template (Kawauchi et al., 2008). The human homolog of Sen1,
Senataxin (Setx), was recently shown to promote Xrn2-depen-
dent transcriptional termination at the 30 end of the B-actin
gene (Skourti-Stathaki et al., 2011). The Sen1 complex was
also recently shown to antagonize transcriptional elongation
and promote premature transcription termination of the yeast
FKS2 gene (Kim and Levin, 2011). Rrp6 is the catalytic subunit
of nuclear exosome, a highly conserved complex possessing
30–50 exoribonuclease activity that exerts an indispensable role
in RNA processing and quality control (Houseley et al., 2006).
Rrp6 is a member of the DEDD family of 30 / 50 exonucleases
that act on nucleic acid by 30 hydrolysis (Moser et al., 1997)
and possesses intrinsic distributive exoribonuclease activity
in vitro.
Here, we describe a mechanism of premature termination and
RNA-dependent transcriptional gene silencing (TGS) at the HIV-
1 promoter. A PTGS-independent function of the micropro-
cessor complex, in cooperation with termination factors, Setx
and Xrn2, regulates RNAPII pausing and premature termination,
whereas additional processing of the cleavage product by Rrp6
generates a small RNA that represses transcription. Modifica-
tions to the local chromatin architecture restrict access of
RNAPII to the promoter, thereby limiting transcriptional output.
RESULTS
Microprocessor Regulates HIV-1 Transcription
Independently of the RNAi Pathway
Given the resemblance between TAR RNA and the stem-loop
structure of miRNA, we hypothesized that microprocessor may
play a role in transcriptional repression and premature termina-
tion at the HIV-1 promoter. To determine whether micropro-
cessor can regulate transcription independently of PTGS, RNAi
directed against components of PTGS was performed in HeLa
cells containing a stably integrated LTR linked to a luciferase
reporter gene (HeLa-LTR-luc; du Che´ne´ et al., 2007; Lassot
et al., 2007). Knockdown of either Drosha or Dgcr8 increased
the abundance of transcripts emanating from an integrated
LTR, as measured by real-time PCR, and corresponding lucif-
erase activity (Figure 1A; see Figure S1A available online). Impor-
tantly, the effect of Drosha and Dgcr8 is independent of small1148 Cell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc.RNA-mediated PTGS because invalidation of this pathway using
small interfering RNA (siRNA) to Dicer, Lsm1, Rck/p54, GW132,
TRBP, Xrn1, Ago1, or Ago2 had no effect (Figures 1A, S1A, and
S1B). To determine whether microprocessor regulates the level
of LTR transcription independently of PTGS, Nuclear Run-On
transcription assay (NRO) was performed in cells knocked
down for RNAi factors. The rate of transcription from the HIV-1
LTR was increased after knockdown of Drosha and Dgcr8, but
not other PTGS factors as compared to control cells (Figure 1B).
Enhanced basal LTR-luc activity after Drosha knockdown was
rescued by expression of a Drosha siRNA-resistant mutant (Fig-
ure S1C). To determine whether microprocessor also modulated
basal transcription of full-length HIV-1, cells were infected with
HIV-1 that lacks the transactivator protein, Tat, and subjected
to RNAi against microprocessor or Rck/p54. Nascent transcrip-
tion was analyzed by NRO using primers in the Gag region of
HIV-1. Knockdown of microprocessor, but not Rck/p54,
enhanced transcription of full-length HIV-1 (Figure S1D). Taken
together, these experiments point to a PTGS-independent func-
tion for Drosha and Dgcr8 acting as transcriptional repressors of
the HIV-1 LTR.
Microprocessor Regulates RNAPII Processivity and
Chromatin Organization at the HIV-1 Promoter
To further characterize the involvement of Drosha and Dgcr8 in
HIV-1 LTR transcriptional repression, we analyzed the conse-
quence of their knockdown on the recruitment and modification
of RNAPII at the LTR using chromatin immunoprecipitation
(ChIP) assay. Knockdown of Drosha or Dgcr8 (Figure 1C)
enhanced RNAPII occupancy at the viral promoter and across
the gene body (Figure 1D). Importantly, phosphorylation of
RNAPII Ser5 and Ser2 was increased when Drosha or Dgcr8
levels were reduced. This experiment suggests that the
enhanced recruitment of RNAPII after Drosha and Dgcr8 knock-
down is accompanied by modifications required for promoter
clearance and processive transcription elongation at the HIV-1
promoter.
Chromatin organization, particularly nucleosome1 (Nuc1)
localized at approximately 100 nt after the TSS of the HIV-1
promoter, is known to play a role in regulating transcription
from the integrated LTR (Bisgrove et al., 2005). Interestingly,
knockdown of Drosha/Dgcr8 had no effect when HIV-1 LTR-
luc was transiently transfected in HeLa cells, suggesting that
microprocessor-mediated repression may depend on a properly
chromatinized environment (data not shown). Thus, we analyzed
the consequence of Drosha and Dgcr8 knockdown on chromatin
marks associated with Nuc1. As previously shown by du Che´ne´
et al. (2007), transcriptionally inactive HIV-1 LTR is associated
with histone H3 repressive marks, H3K9me3 and H3K27me3.
Knockdown of Drosha and Dgcr8 diminished these repressive
marks and significantly increased H3K36me3 that is associated
with transcription elongation (Figure 1E). Consistent with loss of
H3K9me3, association of Hp1gwith the repressed LTR was also
reduced after Drosha and Dgcr8 knockdown (Figure 1F). These
experiments suggest that Drosha and Dgcr8 maintain the chro-
matin at the HIV-1 LTR in a repressed state. Their loss promoted
the establishment of a transcriptionally competent chromatin
environment.
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Figure 1. Drosha and Dgcr8 Are Transcrip-
tional Repressors of the Integrated HIV-1
Promoter
(A and B) RNA isolated from HeLa LTR-Luc cells
transfected with the indicated siRNAs was
analyzed by reverse-transcription q-PCR andNRO
using the primers indicated on the schematic
above the graphs. Values were normalized to that
of GAPDH in the same samples. The result for Scr-
treated cells was attributed a value of 1. The
knockdown of specific factors was validated by
immunoblot (right).
(C) Validation of RNAi knockdowns by immunoblot
using the indicated antibodies.
(D) ChIP assay was performed using the indicated
antibodies and chromatin prepared from HeLa
LTR-Luc cells transfected with control (Si Scr),
Drosha, or Dgcr8 siRNAs as indicated. Locations
of primers used are indicated on the schematic
above the graphs. The amount of immunoprecip-
itatedmaterial for each PCRwas normalized to the
input DNA.
(E) Native ChIP was performed using the indicated
antibodies and chromatin from cells transfected
with the indicated siRNAs. The promoter region
was amplified by q-PCR. The amount of immu-
noprecipitated material was normalized to the
input DNA.
(F) ChIP was performed using anti-HP1g or
a control IgG and chromatin prepared from HeLa
LTR-Luc cells transfected with the indicated
siRNAs. The promoter region was amplified by q-
PCR. The amount of immunoprecipitated material
was normalized to the input DNA.
All graphs show mean ± SE from three indepen-
dent experiments. See also Figure S1.Microprocessor Is Recruited to the HIV-1 LTR through
TAR RNA
Next, we asked whether Drosha and Dgcr8 are directly associ-
ated with the HIV-1 LTR. ChIP using Drosha- and Dgcr8-specific
antibodies immunoprecipitated the HIV-1 promoter-proximal
region (Figure 2A). Association of Drosha and Dgcr8 with the
LTR is specific because the signal was significantly reduced inCell 150, 1147–1157, SepsiRNA-treated cells. Interestingly, knock-
down of Drosha led to loss of Dgcr8, and
vice versa, suggesting that association of
Drosha and Dgcr8 with the HIV-1 LTR
requires the presence of the two subunits
(Figure 2A). The presence of Drosha and
Dgcr8 at the HIV-1 LTR promoter region
but not at the coding region suggests
that they act at an early step of transcrip-
tion (Figure 2A). Importantly, transcrip-
tional activation of the HIV-1 LTR by Tat
diminished the association of Drosha
and Dgcr8 with the promoter as shown
by ChIP (Figure 2B), suggesting that Tat
overcomes Drosha- and Dgcr8-mediated
transcriptional repression by inducing
their release from the promoter.Drosha and Dgcr8 are known to bind the canonical stem-loop
structure of themiRNAwithin the primarymiRNA transcript (Seitz
and Zamore, 2006). Because HIV-1 produces a stem-loop RNA,
TAR, we hypothesized that TAR RNA may contribute to the
recruitment of Drosha andDgcr8 to the viral promoter. In support
of this hypothesis, pretreatment of chromatin with RNase abol-
ished the association of the RNA-binding component oftember 14, 2012 ª2012 Elsevier Inc. 1149
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Figure 2. HIV-1 TAR RNA Is Required for Drosha and Dgcr8-Medi-
ated Transcriptional Repression of the HIV-1 Promoter
(A) ChIP assaywas performed as in Figure 1 using the indicated antibodies and
chromatin prepared from HeLa LTR-Luc cells transfected with the indicated
siRNAs. Results are defined as enrichment over that of a mock precipitation
with an unrelated IgG antiserum. Locations of primers used to amplify
promoter-proximal and coding region sequences are indicated on the sche-
matic above the graph.
(B) ChIP was performed using the indicated antibodies and chromatin
prepared from HeLa LTR-Luc cells treated with Tat or mock treated as indi-
cated. The presence of HIV-1 promoter region in immunoprecipitated mate-
rials was determined by q-PCR. Results are presented as fold enrichment over
that of a mock precipitation using an unrelated IgG antiserum.
(C) ChIP was performed using the indicated antibodies and chromatin
prepared from HeLa LTR-Luc cells that had been pretreated with RNase or
mock treated as indicated. The presence of HIV-1 promoter-proximal region in
immunoprecipitated materials was determined by q-PCR. Results are pre-
sented as fold enrichment over that of a mock precipitation using an unrelated
IgG antiserum.
(D) ChIP assay was performed using the indicated antibodies and chromatin
prepared from HeLa LTR-Luc (WT) and HeLa LTRDTAR-Luc (DTAR) cells. The
presence of HIV-1 promoter-proximal region in immunoprecipitated materials
was determined by q-PCR. Results are presented as fold enrichment over that
of a mock precipitation using an unrelated IgG antiserum.
1150 Cell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc.microprocessor, Dgcr8, but not RNAPII, with the HIV-1 promoter
region showing that microprocessor association is RNA depen-
dent (Figure 2C). We next generated HeLa cells containing an
integrated TAR-deleted LTR-luciferase construct (LTR-DTAR-
luc). It is important to note that both wild-type (WT) LTR-luc
and LTR-DTAR-luc constructs were inserted individually at the
same position in the genome to avoid an integration position
effect (du Che´ne´ et al., 2007; Tre´and et al., 2006). Deletion of
TAR reduced the association of Drosha and Dgcr8 with the
HIV-1 promoter region as shown by ChIP (Figure 2D). Comparing
basal WT LTR activity to LTRDTAR, we observed up to a 9-fold
increase of luciferase activity, suggesting that deletion of TAR
results in transcriptional derepression of the LTR (Figure S2).
Both WT and TAR-deleted constructs respond similarly to acti-
vation by PMA/Ionomycin when normalized to their own basal
activity excluding the possibility that TAR deletion may affect
the general responsiveness of the promoter (Figure S2). To
determine the importance of TAR sequence in microprocessor-
mediated repression, NRO was performed in HeLa LTR-luc con-
taining either WT or TAR-deleted LTR, and transfected with
control or Drosha-specific siRNA (Figure 2D). Consistent with
increased basal luciferase activity in HeLa LTRDTAR-luc cells,
run-on transcripts were approximately 2-fold higher in TAR-
deleted cells compared to cells containing WT LTR when trans-
fected with Scr siRNA (data not shown). Importantly, LTR
derepression after Drosha knockdown was significantly dimin-
ished in TAR-deleted cells compared to controls (Figure 2E).
Taken together, these experiments show that Drosha and
Dgcr8-mediated transcriptional repression of the HIV-1 LTR
requires the presence of the TAR RNA.
Microprocessor Induces Premature Transcription
Termination at the HIV-1 LTR through the Recruitment
of Setx, Xrn2, and Rrp6
Based on the aforementioned, we built a working model in which
synthesis of TAR RNA leads to recruitment of Drosha and Dgcr8
to the HIV-1 promoter, leading to endoribonucleolytic cleavage
of the nascent TAR-containing transcript by Drosha that initiates
premature termination of transcription. In support of this model,
we first observed that Drosha-mediated repression of the HIV-1
LTR is dependent on its endonuclease activity because overex-
pression of a catalytic mutant resulted in enhanced HIV-1 LTR
expression (Figure S3). To further investigate premature termina-
tion at the LTR, we analyzed the involvement of the Sen1 RNA/
DNA helicase, Setx, which participates in termination of tran-
scription, particularly of short transcripts (Kim et al., 2010; Stein-
metz et al., 2006). Under basal transcription conditions, Setxwas
associated predominantly with the promoter-proximal region
(Figure 3A, Tat). Activation of transcription by Tat resulted in
a shift of Setx to the 30 end of the gene, consistent with a role(E) Nuclei isolated from HeLa LTR-Luc (WT) or HeLa LTRDTAR-Luc (DTAR)
cells transfected with the indicated siRNAs were analyzed by NRO using the
primers indicated. Values were normalized to that of GAPDH in the same
samples. The result for scr-treated cells was attributed a value of 1. The
knockdown of Drosha was validated by immunoblot (bottom).
All graphs show mean ± SE from three independent experiments. See also
Figure S2.
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Figure 3. Drosha-Dependent Recruitment of Setx, Xrn2, and Rrp6 to the HIV-1 Promoter-Proximal Region
(A) ChIP assay was performed using the indicated antibody and chromatin from Tat-treated or siRNA-treated HeLa LTR-Luc cells, as indicated. Locations of
primers used to amplify the promoter-proximal and luc 30 regions are indicated on the schematic above the graphs. Results are presented as fold enrichment over
that of amockprecipitation using anunrelated IgGantiserum.Knockdownefficiency of the siRNAwas assessedby immunoblotting using the indicated antibodies.
(B–E) ChIP assay was performed using the indicated antibody and chromatin from siRNA-treated or Tat-treated HeLa LTR-Luc cells. Unless indicated otherwise,
the promoter-proximal region was amplified by q-PCR. Results are presented as fold enrichment over that of a mock precipitation using an unrelated IgG
antiserum or fold increase relative to the control sample (siScr), which was attributed a value of 1. Knockdown efficiencies of the siRNAs were assessed by
immunoblotting using the indicated antibodies.
(F) NRO performed using nuclei prepared from HeLa LTR-Luc cells transfected with the indicated siRNAs. Regions amplified by PCR are indicated above the
graph. Values were normalized to the amount of GAPDH RNA in the same samples. The result for Scr-treated cells was attributed a value of 1. Knockdown
efficiencies of the siRNAs were assessed by immunoblotting using the indicated antibodies.
All graphs show mean ± SE from three independent experiments. See also Figure S3.
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Figure 4. Small TAR-Derived RNAs Repress LTR Activity
(A) HeLa LTR-Luc (WT) or HeLa LTRDTAR-Luc (DTAR) cells transfected with
control (scr) or Rrp6 siRNA, with or without TAR RNA (1 mg), as indicated, were
harvested for luciferase assay (top) and immunoblotting using the antibodies
indicated (bottom). For each condition, values were normalized to the control
sample that wasmock transfected with TAR RNA, which was assigned a value
of 1.
(B) Northern blot analysis of TAR and TAR-derived RNAs obtained from HIV-1-
infected cells transfected with the indicated siRNAs. RNA decade marker run
in parallel is shown at left.
(C) HeLa LTR-Luc (WT) or HeLa LTRDTAR-Luc (DTAR) cells transfected with
control (scr) or Rrp6 siRNA and the indicated RNA oligonucleotides were
harvested for luciferase assay (top) and immunoblotting using the antibodies
indicated (bottom). For each condition, values were normalized to the control
sample, which was assigned a value of 1.
All graphs represent mean ± SE obtained from at least three independent
experiments. See also Figure S4.in termination of short and long transcripts, respectively. Abla-
tion of Setx by RNAi led to loss of Setx from both the promoter
and 30 end of luciferase (Figure 3A, siSetx, ChIP Setx). Interest-1152 Cell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc.ingly, ablation of Drosha also resulted in a significant shift of
Setx toward the 30 end (Figure 3A, siDrosha, ChIP Setx).
However, ablation of Setx only modestly affected Drosha asso-
ciation (Figure 3A, siSetx, ChIP Drosha). Sen1/Setx cooperates
with the 50–30 exonuclease, Xrn2, which is known to play a role
in transcription termination by RNAPII (Ballarino et al., 2009; Gro-
mak et al., 2006) through subsequent degradation of the nascent
transcript leading to cessation of RNA synthesis and termination
by RNAPII-DNA dissociation. Association of Xrn2 with the HIV-1
promoter region was detected in control cells and was abolished
in Xrn2 knockdown cells (Figure 3B). In support of our model,
recruitment of Xrn2 to the promoter-proximal region was depen-
dent on the presence of microprocessor because knockdown of
Drosha significantly reduced Xrn2 recruitment (Figure 3B).
In addition to providing a substrate for the 50–30 exonuclease,
Xrn2, endonucleolytic cleavage of TAR RNA by Drosha will
generate a free 30 end that could serve as a recruitment signal
for a 30–50 RNase such as Rrp6, which can carry out 30–50 RNA
processing or degradation. We hypothesized that micropro-
cessor-dependent cleavage of HIV-1 TAR might signal Rrp6
recruitment to the LTR. Thus, we tested whether Rrp6 physically
associates with HIV-1 chromatin, and whether its association is
dependent on the microprocessor. ChIP analysis showed that
Rrp6was enriched at both the promoter and coding regions (Fig-
ure 3C). Consistent with the hypothesis that Rrp6 is recruited
following transcript cleavage, knockdown of Drosha diminished
Rrp6 recruitment to the HIV-1 promoter (Figure 3D). Because the
HIV-1 transactivator, Tat, displaces Drosha from the LTR (Fig-
ure 2B), we might expect Tat to affect Rrp6 recruitment. Associ-
ation of Rrp6 with the LTR was reduced by Tat accordingly (Fig-
ure 3E). Thus, Rrp6 is recruited to HIV-1 chromatin in a manner
that depends at least partly on the microprocessor.
To determine whether Setx/Xrn2 termination pathway and
Rrp6 regulate basal transcription from the LTR, NROs were per-
formed in cells in which this pathway was invalidated. Run-on
transcripts were increased following knockdown of Xrn2, Setx,
or Rrp6 (Figure 3F). Interestingly, no significant stabilization of
TAR RNA was detected in Xrn2 or Setx knockdown cells
compared to controls, whereas transcript corresponding to the
coding region was increased (Figure 3F). The lack of TAR RNA
accumulation suggests that the substrate of Xrn2 may be a tran-
script that is cleaved down stream of TAR. Furthermore, neither
Setx nor Xrn2 knockdown increased luciferase activity signifi-
cantly (data not shown), suggesting that the transcripts induced
are not competent for protein synthesis.
Interestingly, an increase of TARRNAwas observed after Rrp6
knockdown (Figure 3F). Thus, in considering how Rrp6 might
contribute to transcriptional repression, we asked whether it
further processes the product of microprocessor cleavage, the
promoter-proximal transcript, TAR, which may be required for
transcriptional repression. In support of this, TAR-containing
RNA, when transfected into control HeLa-LTR-luc cells, further
repressed basal LTR activity (Figure 4A), as described previously
by Klase et al. (2007). However, TAR RNA-mediated repression
was abolished in cells depleted of Rrp6, suggesting that further
processing of TAR occurs in vivo that necessitates Rrp6. To
better understand how TAR RNA can inhibit the LTR, we trans-
fected TAR RNA into HeLa cells carrying a TAR-deleted LTR.
TAR did not inhibit the LTR that lacks the corresponding DNA
sequence (Figure 4A). These results show that TAR RNA is
repressive toward the LTR in cells that express WT levels of
Rrp6 and contain the corresponding TAR DNA sequence.
Rrp6-Dependent Biogenesis of Small TAR RNAs that
Repress HIV-1 LTR Activity
To determine whether small RNAs derived from TAR can be de-
tected in vivo, HIV-1-infected cells were analyzed by small RNA-
sequencing (RNA-seq) (Schopman et al., 2012). Sequences cor-
responding to TAR were identified among the reads (Figure S4).
To determine whether Rrp6 may be implicated in the biogenesis
of the TAR-derived RNAs, northern blotting was performed in
cells transfected with control or Rrp6-specific siRNA (Figure 4B).
Knockdown of Rrp6 diminished the abundance of small TAR
RNAs and increased the abundance of unprocessed TAR RNA
(Figure 4B). To determine whether TAR-derived oligonucleotides
mediate repression, oligonucleotides corresponding to TAR-
derived small RNAs identified in vivo (TAR1 nt 11–28 and TAR2
nt 40–58) were transfected into HeLa-LTR-luc cells (Figure 4C).
The most abundant TAR-derived small RNA identified in vivo,
TAR2 (nt 40–58) (Figure S4), further repressed LTR activity
when compared to a nonsense oligo (NS) or a sequence within
the nontranscribed Sp1 sites of the LTR, whereas the less abun-
dant TAR1 nt 11–28 led to a modest reduction. A TAR-derived
sequence that was not represented among the reads (TAR3 nt
15–35) did not repress LTR activity (data not shown). In contrast
to full-length TAR RNA, TAR oligonucleotides repressed the LTR
in a manner that was independent of Rrp6. Furthermore, small
TAR oligonucleotides were not repressive in cells carrying
a TAR-deleted LTR (Figure 4C). These results show that small
RNAs derived from TAR, whose biogenesis depends on Rrp6,
mediate repression of the LTR through a mechanism that may
involve hybrid formation with TAR DNA sequences.
Microprocessor Regulates Transcription from the HERV
Endogenous Retrovirus and Subset of Cellular Genes
Genome-wide mapping studies revealed promoter-proximal
pausing, shortly after initiation, of RNAPII at 30% of human
genes, establishing postinitiation events as a hallmark of gene
regulation (Core and Lis, 2008; Guenther et al., 2007). Thus, we
asked whether the identified function for the microprocessor
complex in regulating transcription by RNAPII is restricted to
the HIV-1 promoter or if it also occurs at cellular genes. For
this purpose we performed ChIP-sequencing (ChIP-seq) anal-
ysis using chromatin prepared from HeLa cells and antibody
recognizing Drosha. First, the reads were filtered for repetitive
sequences, and revealed a large number of tags with significant
enrichment over input tags, corresponding to annotated GGAAT
satellite sequence and LTR retroelements (Table S1). Interest-
ingly, we noticed that the human endogenous retrovirus
(HERV) families were highly represented among the Drosha-
bound repetitive sequences (Figure 5A). Our analysis does not
allow the determination of whether Drosha binds to each of the
approximate 1,000 copies of HERV-H (de Parseval et al., 2001,
2003), or only a subset of them. However, the presence of
sequences highly similar to env HERV-H genes among the reads
suggests that Drosha binds preferentially to nearly full-lengthCcopies. Three major regions within the HERV-H sequence were
found enriched in Drosha: 50 and 30 LTRs and regions within
the middle of the genome (Figure 5B). The presence of Drosha
at HERV-H was confirmed by ChIP using specific oligonucleo-
tides (Figure 5D, top). Interestingly, knockdown of Drosha results
in enhanced recruitment of RNAPII, in an elongation-competent
form, to the HERV-H locus (Figure 5C) and an increase in nascent
transcription as measured by NRO (Figure 5D, bottom). These
data suggest that microprocessor-mediated transcriptional
repression by RNAPII may be an ancient mechanism of regula-
tion controlling the replication of endogenous retroviruses.
Next, reads were filtered for human genes. Our analysis revealed
that Drosha associates with 461 genes, none of which is anno-
tated asmiRNA-encoding genes (Table S2). Specific association
of Drosha was confirmed by ChIP for five randomly selected
genes in control and Drosha knockdown cells (Figure 5D, top).
Nuclear run-on transcription analysis showed that ablation of
Drosha increased transcription from these genes (Figure 5D,
bottom). Furthermore, knockdown of Dicer or GW182 had no
significant effect on their expression as measured by reverse-
transcription quantitative PCR (q-PCR) (data not shown), sug-
gesting that microprocessor-mediated regulation of these genes
is RNAi independent. These results suggest that the micropro-
cessor is physically associated with a subset of cellular genes
and is implicated in their transcriptional regulation. To determine
whether microprocessor affects RNAPII distribution across
these genes, the traveling ratio (TR) of RNAPII in control and
siDrosha samples was calculated as described previously by
Rahl et al. (2010). In control cells the TR was 1 at most genes
analyzed, suggesting that they show signs of RNAPII pausing
(Figure 5E). In Drosha knockdown cells the TRwas 1, suggesting
that the genes were actively transcribing.
DISCUSSION
Our data demonstrate a mechanism of RNA-dependent TGS
that depends on a PTGS-independent function for the micropro-
cessor complex. In cooperation with the termination factors,
Setx and Xrn2, and Rrp6, microprocessor regulates RNAPII
pausing and premature termination at the HIV-1 promoter.
Based on data presented, we propose a model for the establish-
ment of a repressive cycle of transcription (Figure 5F). Recruit-
ment of the microprocessor to the nascent TAR RNA leads to
cleavage of the TSS transcript by Drosha, which generates non-
adenylated TAR on the 50 side of the cut, and an uncapped tran-
script 30 to the cut. The uncapped RNA serves as a signal for
recruitment of the termination factor, Xrn2, which degrades the
ongoing transcript, leading to termination of transcription,
whereas the free 30 end of TAR signals recruitment of Rrp6. By
further processing the cleavage product, an RNA species is
generated that represses transcription. Access of RNAPII to
the promoter becomes severely restricted, leading to transcrip-
tional repression. In support of this model, (1) knockdown of
Drosha/Dgcr8 diminishes recruitment of termination factors,
Setx and Xrn2, and Rrp6 to the promoter-proximal region, and
(2) biogenesis of a repressive small TAR-derived RNA depends
on Rrp6. Consequently, microprocessor facilitates the establish-
ment of transcriptionally repressive chromatin. Thus, inell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc. 1153
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Figure 5. ChIP-seq Analysis Reveals the Endogenous Loci that Are Targets for Drosha
(A) Pie charts summarizing the relative abundance of LINES, SINES, LTR elements, and DNA transposons in the human genome (left) and those bound by Drosha
(right). The observed and expected numbers of tags are significantly different (chi-square test, p < 1015). See also Table S1.
(B) Chr6:21,360,000–21,368,000 region containing a HERV-H endogenous retrovirus. Gray triangles represent the two LTRs. Pink, violet, and blue boxes
represent genomic fragments whose translations have similarities with Gag, Pol, and Env retroviral proteins. ChIP-seq tags density difference between Drosha
siRNA and control conditions along the sequence. Positive values indicate an excess of mapped tags in the Drosha condition.
(C) Experiment was performed as in (B) except that RNAPII, RNAPII ser5, and RNAPII ser2 antibodies were used for ChIP-seq.
(D) Analysis of genes targeted by Drosha. HeLa LTR-Luc cells transfected with the indicated siRNA were analyzed by ChIP assay using antibody against Drosha
(top) or by NRO (bottom). Regions amplified by q-PCR using specific oligonucleotides are indicated. ChIP results are presented as fold enrichment over that of
a mock precipitation using an unrelated IgG antiserum. For NRO, values were normalized to the amount of GAPDH RNA in the same samples. The result for Scr-
treated cells was attributed a value of 1. All graphs show mean ± SE from at least three independent experiments. See also Table S2.
(E) TR of RNAPII is modified by Drosha. ChIP-seq data using anti-RNAPII performed on chromatin from HeLa LTR-Luc cells transfected with the indicated siRNA
were analyzed, and the TR of RNAPII was determined.
(F) A proposed model for premature termination and transcriptional repression at the HIV-1 promoter. See text for details.agreement with reports showing that small RNA-mediated chro-
matin remodeling and TGS can be induced in mammalian cells
(Affymetrix ENCODE Transcriptome Project; Cold Spring Harbor1154 Cell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc.Laboratory ENCODE Transcriptome Project, 2009; Benhamed
et al., 2012; Cernilogar et al., 2011; Guang et al., 2010; Rahl
et al., 2010; Seila et al., 2008), we propose that the
microprocessor, in concert with Setx, Xrn2, and Rrp6, estab-
lishes TGS at the viral promoter. This mechanism of repression
is dynamic because it depends on the availability and recruit-
ment of the different factors involved. Furthermore, it is depen-
dent on a low level of ongoing transcription to provide the RNA
component, which may form R loop or RNA:DNA hybrids that
have been linked to the recruitment of repressive enzymatic
complexes (Schmitz et al., 2010). Consistently, small TAR
RNA-mediated repression requires the presence of the corre-
sponding DNA sequence. Additionally, low-level transcription
is important to prevent nucleosome assembly over the TSS
that could result in more profound transcriptional repression (Gil-
christ et al., 2010).
Genome-wide studies have firmly established that a significant
proportion of genes undergo promoter-proximal pausing of
RNAPII following the synthesis of a short transcript. However,
it is currently unclear whether such polymerases remain in
a paused state until their eventual release into productive elon-
gation or whether they enter a termination pathway, thus clearing
the way for new rounds of initiation (Nechaev and Adelman,
2011). Our data suggest that RNAPII pausing at the HIV-1
promoter under nonactivating conditions leads to premature
termination of transcription that is initiated by the endonuclease
activity of microprocessor toward TAR RNA. ChIP-seq data
further indicate that a similarmechanismmay operate at a subset
of cellular genes. Consistent with this idea, Xrn2 and mRNA-de-
capping factors were recently identified at the 50 end of a large
number of paused genes, and loss of these factors correlated
with enhanced elongation (Brannan et al., 2012). Thus, it appears
likely that promoter-proximal RNAPII detected on a genome-
wide scale represents a pastiche of both paused and terminated
polymerases. Further studies will be required to discriminate
between these outcomes at specific genes.
The finding that Drosha and DGCR8 are associated with
a subset of cellular genes that are not known to encode miRNA
supports the idea that these factors have additional functions in
transcription. A highly abundant class of noncoding transcripts
corresponds to small RNAs that appear to arise from polymer-
ases that have stalled shortly after initiation (Affymetrix ENCODE
Transcriptome Project; Cold Spring Harbor Laboratory ENCODE
Transcriptome Project, 2009; Core et al., 2008; Seila et al., 2008),
and which have been shown to downregulatemyc gene expres-
sion (Affymetrix ENCODE Transcriptome Project; Cold Spring
Harbor Laboratory ENCODE Transcriptome Project, 2009). We
show that repression of the LTR can be enhanced by transfection
of small RNAs, in an Rrp6-dependent manner. Thus, in agree-
ment with reports showing that small RNA-mediated chromatin
remodeling and TGS can be induced in mammalian cells (Affy-
metrix ENCODE Transcriptome Project; Cold Spring Harbor
Laboratory ENCODE Transcriptome Project, 2009; Guang
et al., 2010; Rahl et al., 2010; Seila et al., 2008), we propose
that the microprocessor, together with Setx, Xrn2, and Rrp6,
initiates premature termination of transcription and TGS at the
HIV-1 promoter and a subset of cellular genes.
Antiretroviral treatment (ART) potently controls HIV replication
in infected individuals but does not eradicate the virus due, in
part, to the establishment of a reservoir of stably integrated
provirus that is transcriptionally silent. Establishment of the silentCreservoir has been shown to depend on chromatin repression
and a block to transcription elongation (Siliciano and Greene,
2011). Microprocessor-mediated TGS at the HIV promoter may
have important implications in the establishment of a transcrip-
tionally silent viral reservoir. Consistently, we have previously
shown that knockdown of Drosha in PBMCs isolated from
patients with HIV under suppressive therapy results in virus reac-
tivation through RNAi-dependent and -independent mecha-
nisms (Triboulet et al., 2007). Here, we show thatmicroprocessor
modulates transcription from silent HIV-1 provirus. Further work
is required to determine whether microprocessor in concert with
the Setx, Xrn2, and Rrp6 plays a role in HIV transcriptional
silencing leading to the establishment and/or the maintenance
of the transcriptionally latent viral reservoir.
EXPERIMENTAL PROCEDURES
Antibodies and Plasmids
Rabbit anti-Dgcr8, mouse anti-Dicer, Rabbit anti-Rrp6, mouse mAb anti-RNA
Polymerase II CTD (clone 4H8), and rabbit anti-H3K36me3 were purchased
from Abcam (Cambridge). Rabbit anti-Drosha (Up07717), mouse anti-Hp1g
(Up05690), and rabbit anti-H3K27me3 (Up07449) were purchased from Milli-
pore. Rabbit anti-RNA Polymerase II CTD Phospho S2, rabbit anti-RNA Poly-
merase II CTD Phospho S5, rabbit anti-Xrn1, rabbit anti-Rck/p54, and rabbit
anti-Setx were purchased from Bethyl (Montgomery, TX, USA). Mouse anti-
Flag (M2), mouse anti-tubulin (clone DM1A), rabbit anti-Drosha, rabbit anti-
Lsm1, and normal mouse IgA and IgG were purchased from Sigma-Aldrich
(St. Louis). Rabbit anti-Xrn2 was purchased from ProteinTech Group. Rabbit
anti-GW182 was purchased from Novus Biologicals (Cambridge). Rabbit
anti-TRBP1 was obtained from Dr. K.-T. Jeang and has been described previ-
ously by Bennasser et al. (2006). Plasmids encoding WT Drosha and the
mutant lacking the endonucleolytic activity (E1045Q/E1222Q) have been
described previously by Han et al. (2006).
Cell Culture, Transfection, and Treatment
HeLa LTR-Luc and HeLa LTRDTAR-Luc cells (Tre´and et al., 2006) were ob-
tained from Dr. Ste´phane Emiliani (Institut Cochin, Paris) and were propagated
in Dulbecco’s modified Eagle’s medium (DMEM; Lonza, Basel) supplemented
with 10% fetal bovine serum (FBS; AbCys, Paris) and antibiotics. For transfec-
tion of siRNAs, HeLa cells harboring a stably integrated pNL4-3 (Tat minus)
provirus or HeLa-LTR-luc cells were transfected with siRNAs (10 or 30 nM final
concentration) using oligofectamine (Invitrogen, Paisley, UK) or Interferin
(PolyPlus Transfection, Illkirch, France) according to the manufacturers’
instructions. Plasmid transfection was performed with Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA) or Jet PEI (PolyPlus Transfection) according
to the manufacturers’ instructions. Where indicated, cells were treated with
phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) overnight. Treatment
with GST and GST-Tat was carried out as previously described by du Che´ne´
et al. (2007).
For transfection of RNAs, HeLa-LTR-luc cells were transfected with a first
round of siRNA (20 nM final concentration) using oligofectamine according
to the manufacturers’ instructions. Twenty-four hours later, the cells were
transfected a second time with the same concentration of siRNA supple-
mented with 1 mg of the indicated RNA oligonucleotide, unless otherwise
stated. Cells were harvested at approximately 60 hr for luciferase activity
and western blot.
siRNAs and q-PCR Oligonucleotides and RNA Oligonucleotides
Double-stranded RNA oligonucleotides used for RNAi were purchased from
Eurofins MWG Operon (Ebersberg, Germany). Target sequences are shown
in Extended Experimental Procedures. PCR primer sequences to amplify
TAR, early, luc (coding region), luc 30, and GAPDH-Q have been described
elsewhere (Nakamura et al., 2012). Sequences of additional oligonucleotide
pairs used are shown in Extended Experimental Procedures. TAR RNA wasell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc. 1155
purchased as a purified RNA oligonucleotide from Thermo Scientific. NS, Sp1
and TAR 1, TAR2 and TAR3 RNA oligonucleotides were purchased fromMWG
Operon. The sequences are shown in Extended Experimental Procedures.
Luciferase Assays and Immunoblot
Luciferase activity was measured according to the manufacturer’s protocol
(Promega, Madison, WI, USA) and was normalized to cell protein concentra-
tion. Immunoblot was performed as described previously (Kiernan et al., 2001).
Quantitative RT-PCR
Total RNA was extracted from cells using TRIzol (Invitrogen) according to the
manufacturer’s instructions and reverse transcribed using SuperScript First-
Strand Synthesis System for RT-PCR (Invitrogen). Reverse-transcription prod-
ucts were amplified by real-time PCR (LightCycler; Roche) using QuantiTect
SYBR Green (QIAGEN, Germantown, MD, USA) with the indicated oligonucle-
otides. q-PCR cycling conditions are available on request. Unless otherwise
stated, samples were analyzed by reverse-transcription q-PCR using the
specific oligonucleotide pairs indicated, and GAPDH. The amount of the indi-
cated mRNA was normalized to the amount of GAPDHmRNA in each sample,
and the values were normalized to those for the control transfection (Scr),
which was attributed a value of one (1).
ChIP
Cells were transfected as indicated in the figures. Following 64 hr incubation,
cells were washed and harvested for native ChIP, performed as described
previously (Wagschal et al., 2007), or crosslink ChIP, which was performed
as described previously (Nakamura et al., 2012) except that chromatin was
precleared at 4C for 2 hr with 20 ml protein A or Gmagnetic beads (Invitrogen)
that had been preblocked with 1% BSA. Antibodies (2 mg) were incubated for
4 hr with 20 ml of blocked magnetic beads before the addition of sonicated
chromatin overnight at 4C. An aliquot was amplified by real-time PCR as
described previously by Lassot et al. (2007) using specific oligonucleotide
primers indicated. An aliquot of chromatin was amplified in parallel, and values
obtained for immunoprecipitates were normalized to values for chromatin
(percent [%] input DNA).
RNase treatment of chromatin was performed as described previously by
Abruzzi et al. (2004) except that cells were prefixed for 2.5min prior to the addi-
tion of RNase cocktail (Ambion). ChIP was then performed as described
above.
Nuclear Run-On Transcription
Run-on transcription was performed as described previously by Core et al.
(2008). Run-on transcripts were reverse transcribed and quantified by PCR
using the oligonucleotide pairs indicated. Results were normalized to the
amount of GAPDH run-on transcript in the same sample.
Small RNA-seq and Northern Blotting
Small RNA-seq and northern blotting were performed as described previously
by Schopman et al. (2012). Full-length TAR RNA was used as a probe in
northern blotting.
ChIP-seq
Sample preparation was performed using the ChIP-seq sample preparation kit
from Illumina (ref. IP-102-1001) according to the manufacturer’s instructions.
Briefly, 10 ng of sonicated chromatin was repaired using amix of T4 DNA Poly-
merase, KlenowDNAPolymerase, and T4 Polynucleotide kinase. The resulting
fragments were A tailed using Klenow DNA polymerase (30–50 exo minus). Illu-
mina’s adapters were ligated to the DNA fragment using T4 DNA ligase. The
libraries were size selected at 200 bp (± 25 bp) on a 2% agarose gel. Once ex-
tracted from agarose, 18 cycles of PCR were performed on the libraries using
Illumina’s PCR primers. Each library was diluted to 10 nM, denatured, and
diluted again to 8 pM. A total of 100 ml of the diluted library was hybridized
on a lane of an Illumina’s Flow Cell. Clustering and 36 cycle sequencing
were performed according to Illumina’s instructions.
Reads that aligned to unique positions in the genome were processed using
peak-calling MACS (Zhang et al., 2008) with mfod R10 and p = 105 for the
binomial distribution. Peaks with false discovery rate (FDR) %1% were1156 Cell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc.conserved. Target genes (503) were identified when at least 1 nt overlaps
between gene and peak positions. Calculation of RNAPII TR that compares
the ratio between Pol II density in the promoter and in the gene region was per-
formed as described previously by Rahl et al. (2010).
Reads that aligned tomultiple genomic locations were aligned on the human
Repbase. Differentially expressed repeat tags were identified by a Fisher’s
exact test with Benjamini-Hochberg method to compute the FDR and a cutoff
p value of 0.01 as implemented in the SAGE Genie resource (http://cgap.nci.
nih.gov/SAGE).
All Drosha ChIP-seq tags filtered against Repbase were aligned on all
human genomic regions known to contain a copy of an endogenous retrovirus
member of the HERV-H family. Only tags that fully and exactly aligned were
considered. Because the HERV-H family has several hundred copies in the
human genome, we visually checked the tag density over the hundred copies
on which the number of aligned tags was maximal without noticing any qual-
itative difference. The HERV-H copy on the Chr6:21,360,000–21,368,000
region was then selected for further analysis because it is one of the copies
that has a high number of aligned tags.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.08.004.ACKNOWLEDGMENTS
We thank members of the Molecular Virology and Gene Regulation labs for
critical reading of the manuscript, N. Kim for Drosha WT and mutant plasmids,
and S. Emiliani for HeLa-LTR-luc. ChIP-seq experiments were performed
using MGX-Montpellier facilities. This work was supported by grants from
the ERC (250333), ANR-BLAN-0040, Sidaction, ANRS, and FRM ‘‘e´quipe
labe´llise´e’’ to M.B. and ANRS and Sidaction to R.K. A.W. was supported by
ANR and ERC; E.R. and M.N. by Sidaction; P.B. by ANRS; S.L.-C. by ERC;
X. Chen by CNRS and FRM; K.Z. by CNRS; O.M. by RTRS grand Sud; and
B.B. by The Netherlands Organization for Scientific Research (NWO-CW,
Top grant).
Received: September 24, 2011
Revised: May 29, 2012
Accepted: August 2, 2012
Published: September 13, 2012
REFERENCES
Abruzzi, K.C., Lacadie, S., and Rosbash, M. (2004). Biochemical analysis of
TREX complex recruitment to intronless and intron-containing yeast genes.
EMBO J. 23, 2620–2631.
Affymetrix ENCODE Transcriptome Project; Cold Spring Harbor Laboratory
ENCODE Transcriptome Project. (2009). Post-transcriptional processing
generates a diversity of 50-modified long and short RNAs. Nature 457, 1028–
1032.
Ballarino, M., Pagano, F., Girardi, E., Morlando,M., Cacchiarelli, D., Marchioni,
M., Proudfoot, N.J., and Bozzoni, I. (2009). Coupled RNA processing and tran-
scription of intergenic primary microRNAs. Mol. Cell. Biol. 29, 5632–5638.
Benhamed, M., Herbig, U., Ye, T., Dejean, A., and Bischof, O. (2012). Senes-
cence is an endogenous trigger for microRNA-directed transcriptional gene
silencing in human cells. Nat. Cell Biol. 14, 266–275.
Bennasser, Y., Yeung, M.L., and Jeang, K.T. (2006). HIV-1 TAR RNA subverts
RNA interference in transfected cells through sequestration of TAR RNA-
binding protein, TRBP. J. Biol. Chem. 281, 27674–27678.
Bisgrove, D., Lewinski, M., Bushman, F., and Verdin, E. (2005). Molecular
mechanisms of HIV-1 proviral latency. Expert Rev. Anti Infect. Ther. 3,
805–814.
Brannan, K., Kim, H., Erickson, B., Glover-Cutter, K., Kim, S., Fong, N., Kie-
mele, L., Hansen, K., Davis, R., Lykke-Andersen, J., and Bentley, D.L.
(2012). mRNA decapping factors and the exonuclease Xrn2 function in wide-
spread premature termination of RNA polymerase II transcription. Mol. Cell
46, 311–324.
Bre`s, V., Yoh, S.M., and Jones, K.A. (2008). The multi-tasking P-TEFb
complex. Curr. Opin. Cell Biol. 20, 334–340.
Cernilogar, F.M., Onorati, M.C., Kothe, G.O., Burroughs, A.M., Parsi, K.M.,
Breiling, A., Lo Sardo, F., Saxena, A., Miyoshi, K., Siomi, H., et al. (2011). Chro-
matin-associated RNA interference components contribute to transcriptional
regulation in Drosophila. Nature 480, 391–395.
Core, L.J., and Lis, J.T. (2008). Transcription regulation through promoter-
proximal pausing of RNA polymerase II. Science 319, 1791–1792.
Core, L.J., Waterfall, J.J., and Lis, J.T. (2008). Nascent RNA sequencing
reveals widespread pausing and divergent initiation at human promoters.
Science 322, 1845–1848.
de Parseval, N., Casella, J., Gressin, L., and Heidmann, T. (2001). Character-
ization of the three HERV-H proviruses with an open envelope reading frame
encompassing the immunosuppressive domain and evolutionary history in
primates. Virology 279, 558–569.
de Parseval, N., Lazar, V., Casella, J.F., Benit, L., and Heidmann, T. (2003).
Survey of human genes of retroviral origin: identification and transcriptome
of the genes with coding capacity for complete envelope proteins. J. Virol.
77, 10414–10422.
du Che´ne´, I., Basyuk, E., Lin, Y.L., Triboulet, R., Knezevich, A., Chable-Bessia,
C., Mettling, C., Baillat, V., Reynes, J., Corbeau, P., et al. (2007). Suv39H1 and
HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional
silencing and post-integration latency. EMBO J. 26, 424–435.
Gilchrist, D.A., Dos Santos, G., Fargo, D.C., Xie, B., Gao, Y., Li, L., and Adel-
man, K. (2010). Pausing of RNA polymerase II disrupts DNA-specified nucleo-
some organization to enable precise gene regulation. Cell 143, 540–551.
Gromak, N., West, S., and Proudfoot, N.J. (2006). Pause sites promote tran-
scriptional termination of mammalian RNA polymerase II. Mol. Cell. Biol. 26,
3986–3996.
Guang, S., Bochner, A.F., Burkhart, K.B., Burton, N., Pavelec, D.M., and Ken-
nedy, S. (2010). Small regulatory RNAs inhibit RNA polymerase II during the
elongation phase of transcription. Nature 465, 1097–1101.
Guenther, M.G., Levine, S.S., Boyer, L.A., Jaenisch, R., and Young, R.A.
(2007). A chromatin landmark and transcription initiation at most promoters
in human cells. Cell 130, 77–88.
Han, J., Lee, Y., Yeom, K.H., Nam, J.W., Heo, I., Rhee, J.K., Sohn, S.Y., Cho,
Y., Zhang, B.T., and Kim, V.N. (2006). Molecular basis for the recognition of
primary microRNAs by the Drosha-DGCR8 complex. Cell 125, 887–901.
Han, J., Pedersen, J.S., Kwon, S.C., Belair, C.D., Kim, Y.K., Yeom, K.H., Yang,
W.Y., Haussler, D., Blelloch, R., and Kim, V.N. (2009). Posttranscriptional
crossregulation between Drosha and DGCR8. Cell 136, 75–84.
Houseley, J., LaCava, J., and Tollervey, D. (2006). RNA-quality control by the
exosome. Nat. Rev. Mol. Cell Biol. 7, 529–539.
Kawauchi, J., Mischo, H., Braglia, P., Rondon, A., and Proudfoot, N.J. (2008).
Budding yeast RNA polymerases I and II employ parallel mechanisms of tran-
scriptional termination. Genes Dev. 22, 1082–1092.
Kiernan, R.E., Emiliani, S., Nakayama, K., Castro, A., Labbe´, J.C., Lorca, T.,
Nakayama Ki, K., and Benkirane, M. (2001). Interaction between cyclin T1
and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the pro-
teasome. Mol. Cell. Biol. 21, 7956–7970.
Kim, H., Erickson, B., Luo, W., Seward, D., Graber, J.H., Pollock, D.D., Megee,
P.C., and Bentley, D.L. (2010). Gene-specific RNA polymerase II phosphoryla-
tion and the CTD code. Nat. Struct. Mol. Biol. 17, 1279–1286.
Kim, K.Y., and Levin, D.E. (2011). Mpk1 MAPK association with the Paf1
complex blocks Sen1-mediated premature transcription termination. Cell
144, 745–756.CKim, V.N., Han, J., and Siomi, M.C. (2009). Biogenesis of small RNAs in
animals. Nat. Rev. Mol. Cell Biol. 10, 126–139.
Klase, Z., Kale, P., Winograd, R., Gupta, M.V., Heydarian, M., Berro, R.,
McCaffrey, T., and Kashanchi, F. (2007). HIV-1 TAR element is processed by
Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral
LTR. BMC Mol. Biol. 8, 63.
Lassot, I., Latreille, D., Rousset, E., Sourisseau, M., Linares, L.K., Chable-Bes-
sia, C., Coux, O., Benkirane, M., and Kiernan, R.E. (2007). The proteasome
regulates HIV-1 transcription by both proteolytic and nonproteolytic mecha-
nisms. Mol. Cell 25, 369–383.
Moser, M.J., Holley, W.R., Chatterjee, A., and Mian, I.S. (1997). The proof-
reading domain of Escherichia coli DNA polymerase I and other DNA and/or
RNA exonuclease domains. Nucleic Acids Res. 25, 5110–5118.
Nakamura, M., Basavarajaiah, P., Rousset, E., Beraud, C., Latreille, D.,
Henaoui, I.S., Lassot, I., Mari, B., and Kiernan, R. (2012). Spt6 levels are
modulated by PAAF1 and proteasome to regulate the HIV-1 LTR. Retrovirol-
ogy 9, 13.
Nechaev, S., and Adelman, K. (2011). Pol II waiting in the starting gates: regu-
lating the transition from transcription initiation into productive elongation. Bio-
chim. Biophys. Acta 1809, 34–45.
Newman, M.A., and Hammond, S.M. (2010). Emerging paradigms of regulated
microRNA processing. Genes Dev. 24, 1086–1092.
Rahl, P.B., Lin, C.Y., Seila, A.C., Flynn, R.A., McCuine, S., Burge, C.B., Sharp,
P.A., and Young, R.A. (2010). c-Myc regulates transcriptional pause release.
Cell 141, 432–445.
Schmitz, K.M., Mayer, C., Postepska, A., and Grummt, I. (2010). Interaction of
noncoding RNAwith the rDNA promoter mediates recruitment of DNMT3b and
silencing of rRNA genes. Genes Dev. 24, 2264–2269.
Schopman, N.C., Willemsen, M., Liu, Y.P., Bradley, T., van Kampen, A., Baas,
F., Berkhout, B., and Haasnoot, J. (2012). Deep sequencing of virus-infected
cells reveals HIV-encoded small RNAs. Nucleic Acids Res. 40, 414–427.
Seila, A.C., Calabrese, J.M., Levine, S.S., Yeo, G.W., Rahl, P.B., Flynn, R.A.,
Young, R.A., and Sharp, P.A. (2008). Divergent transcription from active
promoters. Science 322, 1849–1851.
Seitz, H., and Zamore, P.D. (2006). Rethinking the microprocessor. Cell 125,
827–829.
Siliciano, R.F., and Greene, W.C. (2011). HIV Latency. Cold Spring Harb. Per-
spect. Med. 1, a007096.
Skourti-Stathaki, K., Proudfoot, N.J., andGromak, N. (2011). Human senataxin
resolves RNA/DNA hybrids formed at transcriptional pause sites to promote
Xrn2-dependent termination. Mol. Cell 42, 794–805.
Steinmetz, E.J., Warren, C.L., Kuehner, J.N., Panbehi, B., Ansari, A.Z., and
Brow, D.A. (2006). Genome-wide distribution of yeast RNA polymerase II
and its control by Sen1 helicase. Mol. Cell 24, 735–746.
Tre´and, C., du Che´ne´, I., Bre`s, V., Kiernan, R., Benarous, R., Benkirane, M.,
and Emiliani, S. (2006). Requirement for SWI/SNF chromatin-remodeling
complex in Tat-mediated activation of the HIV-1 promoter. EMBO J. 25,
1690–1699.
Triboulet, R., Mari, B., Lin, Y.L., Chable-Bessia, C., Bennasser, Y., Lebrigand,
K., Cardinaud, B., Maurin, T., Barbry, P., Baillat, V., et al. (2007). Suppression
of microRNA-silencing pathway by HIV-1 during virus replication. Science 315,
1579–1582.
Ursic, D., Himmel, K.L., Gurley, K.A., Webb, F., and Culbertson, M.R. (1997).
The yeast SEN1 gene is required for the processing of diverse RNA classes.
Nucleic Acids Res. 25, 4778–4785.
Wagschal, A., Delaval, K., Pannetier, M., Arnaud, P., and Feil, R. (2007). Chro-
matin immunoprecipitation (ChIP) on unfixed chromatin from cells and tissues
to analyze histone modifications. CSH Protoc. Published online June 1, 2007.
10.1101/pdb.prot4767.
Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E.,
Nusbaum, C., Myers, R.M., Brown, M., Li, W., and Liu, X.S. (2008). Model-
based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137.ell 150, 1147–1157, September 14, 2012 ª2012 Elsevier Inc. 1157
